Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Chemother ; 17(2): 288-90, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20827562

ABSTRACT

A 49-year-old-woman was diagnosed with tuberculosis of the left humerus. She had received treatment, including rifampicin, for tuberculosis 17 years previously. Treatment was begun with isoniazid, rifampicin, ethambutol, and pyrazinamide, but these were discontinued because of mild neutropenia and thrombocytopenia 2 weeks posttreatment. Rifampicin and ethambutol were readministered after a 4-day interruption; however, generalized purpura appeared several hours later. By the next day, her platelet count was reduced from 160 × 10(3) to 3 × 10(3)/µl. The patient improved rapidly after platelet transfusion and steroid treatment. Readministration of drugs other than rifampicin did not induce thrombocytopenia; therefore, thrombocytopenia was likely due to rifampicin.


Subject(s)
Antitubercular Agents/adverse effects , Rifampin/adverse effects , Thrombocytopenia/etiology , Tuberculosis, Osteoarticular/complications , Tuberculosis, Osteoarticular/drug therapy , Acute Disease , Antitubercular Agents/administration & dosage , Ethambutol/administration & dosage , Female , Humans , Humerus/microbiology , Middle Aged , Rifampin/administration & dosage , Severity of Illness Index , Thrombocytopenia/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...